In this study, we demonstrate, for the first time, that the intracellular form of CYTL1, not the extracellular form, inhibits metabolic reprogramming toward glycolysis, which has been linked to the inhibition of the cell growth and metastasis of breast cancer both in vitro and in vivo. The gene discussed is CYTL1; the disease is breast carcinoma.